medigraphic.com
ISSN 1029-3043 (Electronic)

2022, Number 1

<< Back Next >>

Medicentro 2022; 26 (1)

Factors favouring a worse clinical course of COVID-19 in people with obesity

Hernández RJ, Orlandis GN

Language: Spanish
References: 43
Page: 131-150
PDF size: 509.53 Kb.


ABSTRACT

Introduction: COVID-19 is a disease caused by a new β-coronavirus, which can manifest with a more complex clinical presentation in people with certain comorbidities, on which its evolution may depend; obesity is pointed out among them.
Objective: to describe factors favouring a worse clinical course of COVID-19 in people with obesity.
Methods: SciELO, Pubmed, and Google Scholar were used as search engines for scientific information. The search strategy included the following keywords: SARS-CoV-2, COVID-19 and obesity. Review and journal research articles, as well as web pages referring specifically to the study topic and published generally in Spanish, Portuguese and English languages in less than five years were evaluated. This allowed us 70 articles to be evaluated, of which 43 were referenced.
Conclusions: obesity constitutes a disease that worsens the clinical course of COVID-19 by increasing its morbidity and mortality, which is due to several factors related to excess body fat and its consequences.


REFERENCES

  1. Hernández J. Aspectos clínicos relacionados con el Síndrome Respiratorio Agudo Severo (SARS-CoV-2). Rev Haban Cienc Méd [internet]. 2020 [citado 14 mayo 2020];19:[aprox. 18 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/download/3279/2532

  2. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol [internet]. 2020 [citado 14 mayo 2020];92(4):[aprox. 5 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681

  3. De Wilde AH, Snijder EJ, KikkertM, van Hemert MJ. Host factors in coronavirus replication. Curr Top Microbiol Immunol [internet]. 2018 [citado 14 mayo de 2020];419:[aprox. 42 p.]. Disponible en: https://europepmc.org/article/med/28643204

  4. Sharma A, Tiwari S, Deb MK, Marty JL. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies. Int J Antimicrob Agents [internet]. 2020 [citado 14 mayo 2020];56(2):[aprox. 13 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0924857920302247

  5. Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, et al. Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features. Invest Radiol [internet]. 2020 [citado 21 mar. 2020];55(5):[aprox. 4 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147284/pdf/rli-55-257.pdf

  6. Aguilera O. La asociación de la obesidad con la COVID-19. Bol Cient Cimeq [internet]. 2020 [citado 14 mayo 2020];1(13):[aprox. 1 p.]. Disponible en: https://files.sld.cu/cimeq/files/2020/06/Bol-CCimeq-2020-1-13-pag5.pdf

  7. Centro de Coordinación de Alertas y Emergencias Sanitarias. Enfermedad por coronavirus, COVID-19 [internet]. España: Ministerio de Sanidad de España; 2020 [citado 14 mayo 2020]. Disponible en: https://pnsd.sanidad.gob.es/noticiasEventos/actualidad/2020_Coronavirus/pdf/20200421_INFORME_CIENTIFICO_SANIDAD_COVID-19.pdf

  8. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [internet]. 2020 [citado 14 mayo 2020];395(10223):[aprox. 8 p.]. Disponible en: https://media.tghn.org/articles/99_cases_of_2019_novel_coronavirus_pneumonia_in_Wuhan_China.pdf

  9. Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a Disease: The Obesity Society 2018 Position Statement. Obesity (Silver Spring) [internet]. 2019 [citado 5 mayo 2020];27:[aprox. 2 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.22378

  10. Organización Mundial de la Salud [internet]. Obesidad y sobrepeso. 2020 [citado 30 dic. 2021]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight

  11. Hernández J, Arnold Y, Moncada OM. Prevalencia y tendencia actual del sobrepeso y la obesidad en personas adultas en el mundo. Rev Cubana Endocrinol [internet]. 2019 [citado 30 mayo 2020];30(3):[aprox. 17 p.]. Disponible en: http://www.revendocrinologia.sld.cu/index.php/endocrinologia/article/download/193/167

  12. Gómez R, Valenzuela A. II Consenso Latinoamericano de Obesidad 2017. Perú: Federación Latinoamericana de Sociedades de Obesidad; 2017 [citado 6 mayo 2019]. Disponible en: http://www.administracion.usmp.edu.pe/institutoconsumo/wp-content/uploads/LIBRO-II-CONSENSO-LATINOAMERICANO-DE-OBESIDAD-2017.pdf

  13. Bonet M, Varona P. III Encuesta nacional de factores de riesgo y actividades preventivas de enfermedades no trasmisibles. Cuba 2010-2011 [internet]. La Habana: Editorial Ciencias Médicas; 2015 [citado 14 may 2020]. Disponible en: http://www.bvs.sld.cu/libros/encuesta_nacional_riesgo/encuesta_completo.pdf

  14. Aguilera O. La asociación de la obesidad con la COVID-19. Bol Cient Cimeq [internet]. 2020 [citado 30 mayo 2021];1(13):[aprox. 5 p.]. Disponible en: https://files.sld.cu/cimeq/files/2020/06/Bol-CCimeq-2020-1-13-pag5.pdf

  15. Petrova D, Salamanca E, Rodríguez M, Navarro P, Jiménez JJ, Sánchez MJ. La obesidad como factor de riesgo en personas conCOVID-19: posibles mecanismos e implicaciones. Aten Primaria [internet]. 2020 [citado 30 mayo 2021];52(7):[aprox. 4 p.]. Disponible en: https://www.elsevier.es/es-revista-atencion-primaria-27-articulo-la-obesidad-como-factor-riesgo-S0212656720301657

  16. Grupo de Análisis Científico de Coronavirus del Instituto de Salud Carlos III. Factores de riesgo en la enfermedad por SARS-CoV-2 (COVID-19) [internet]. España: Ministerio de Ciencia e Innovación; 2020 [citado 30 mayo 2021]. Disponible en: https://www.conprueba.es/sites/default/files/informes/2020-06/FACTORES%20DE%20RIESGO%20EN%20LA%20ENFERMEDAD%20POR%20SARS-CoV-2%20%28COVID-19%29_2.pdf

  17. Méndez J. El enigma del coronavirus: por qué unos lo sufren tanto y otros tan poco. "De próxima aparición". 2020 [citado 8 jun. 2021].Disponible en: https://www.agenciasinc.es/Reportajes/El-enigma-del-coronavirus-por-que-unos-lo-sufren-tanto-y-otros-tan-poco

  18. Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality. Obesity [internet]. 2020 [citado 30 mayo 2021];28(6):[aprox. 1 p.]. Disponible en: https://www.sochob.cl/web1/wp-content/uploads/2020/04/Obesity-and-its-Implications-for-COVID%E2%80%9019-Mortality.pdf

  19. Pasquarelli do Nascimento G, Braz de Melo HA, Socorro Faria S, de Oliveira I, Kobinger GP, Grace K. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity. Front Endocrinol [internet]. 2020 [citado 15 sep. 2021];11:[aprox. 1 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399077/

  20. South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol [internet]. 2020 [citado 30 mayo 2020];318(5):[aprox. 6 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191628/

  21. Maier HE, Lopez R, Sanchez N, Ng S, Gresh L, Ojeda S, et al. Obesity Increases the Duration of Influenza A Virus Shedding in Adults. J Infect Dis [internet]. 2018 [citado 14 mayo 2020];218(9):[aprox. 4 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151083/

  22. Jia X, Yin C, Lu S, Chen Y, Liu Q, Bai J. Two Things about COVID-19 Might Need Attention. Preprints [internet]. 2020 [citado 14 mayo 2020];[aprox. 10 p.]. Disponible en: https://www.preprints.org/manuscript/202002.0315/v1/download

  23. Movahed MR, Khoubyari R, Hashemzadeh M, Hashemzadeh M. Obesity is strongly and independently associated with a higher prevalence of pulmonary embolism. Respir Invest [internet]. 2019 [citado 30 mayo 2020];57(4):[aprox. 7 p.]. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S221253451830282X?via%3Dihub

  24. Muscogiuri G, Pugliese G, Barrea L, Savastano S, Colao A. Comentary: Obesity: The "Achilles heel" for COVID-19?. Metabolism Clin Exp [internet]. 2020 [citado 20 mayo 2020];108:[aprox. 8 p.]. Disponible en: https://www.metabolismjournal.com/action/showPdf?pii=S0026-0495%2820%2930115-3

  25. Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. JACC Basic Transl Sci [internet]. 2020 [citado 14 mayo 2020];5(5):[aprox. 18 p.] Disponible en: https://www.jacc.org/doi/pdf/10.1016/j.jacbts.2020.04.002

  26. Murillo LM. SARS-CoV-2 Como Factor de Riesgo Vascular. Rev Med Clín [internet]. 2020 [citado 14 mayo 2020];4(2):[aprox. 4 p.]. Disponible en: https://medicinaclinica.org/index.php/rmc/article/download/265/320/1361

  27. Ghelichkhani P, Esmaeili M. Prone position in management of COVID-19 patients; a commentary. Arch Acad Emerg Med [internet]. 2020 [citado 14 de mayo 2020];8(1):[aprox. 3 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158870/pdf/aaem-8-e48.pdf

  28. Raveendrana R, Won J, Chung F. Morbid obesity, sleep apnea, obesity hypoventilation syndrome: Are we sleepwalking into disaster? Perioper Care Oper Room Manag [internet]. 2017 [citado 20 mayo 2020];9:[aprox. 8 p.]. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S2405603017300456

  29. Pazarli AC, Ekiz T, Ilik F. Coronavirus disease 2019 and obstructive sleep apnea syndrome. Sleep Breath [internet]. 2020 [citado 20 mayo 2020];25(1):[aprox. 5 p.]. Disponible en: https://link.springer.com/content/pdf/10.1007/s11325-020-02087-0.pdf

  30. Barceló A, Elorza MA, Barbé F, Santos C, Mayoralas LR, Agustí AGN. Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur Respir J [internet]. 2001 [citado 14 mayo 2020];17(4):[aprox. 4 p.]. Disponible en: https://erj.ersjournals.com/content/erj/17/4/728.full.pdf

  31. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [internet]. 2020 [citado 14 mayo 2020];395(10229):[aprox. 8 p.]. Disponible en: http://www.epi.uff.br/wp-content/uploads/2013/10/coronavirusriskfactors.pdf

  32. Pinto JA, Ribeiro DK, Cavallini AF, Duarte C, Freitas G. Comorbidities associated with obstructive sleep apnea: a retrospective study. Int Arch Otorhinolaryngol [internet]. 2016 [citado 14 mayo 2020];20(2):[aprox. 5 p.]. Disponible en: https://www.scielo.br/j/iao/a/9DQpQGdJzJ9hW7nKWznW6yJ/?format=pdf&lang=en

  33. Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol [internet]. 2020 [citado 20 mayo 2020];30:[aprox. 8 p.]. Disponible en: https://link.springer.com/content/pdf/10.1007/s00330-020-06801-0.pdf

  34. Gami AS, Olson EJ, Shen WK. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol [internet]. 2013 [citado 14 mayo 2020];62(7):[aprox. 6 p.]. Disponible en: https://www.jacc.org/doi/full/10.1016/j.jacc.2013.04.080

  35. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. New England J Med [internet]. 2017 [citado 14 mayo 2020];377(1):[aprox. 14 p.]. Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMoa1614362

  36. Honce R, Schultz Cherry S. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol [internet]. 2019 [citado 30 mayo 2020]:[aprox. 5 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523028/

  37. Suen CM, Hui DS, Memtsoudis SG, Chung F. Obstructive Sleep Apnea, Obesity, and Noninvasive Ventilation: Considerations During the Coronavirus Disease 2019 Pandemic. Anesth Analg [internet]. 2020 [citado 30 mayo 2020]:[aprox. 5 p.]. Disponible en: https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7202104&blobtype=pdf

  38. Karnatovskaia LV, Lee AS, Bender SP, Talmor D, Festic E. Obstructive sleep apnea, obesity, and the development of acute respiratory distress syndrome. J Clin Sleep Med [internet]. 2014 [citado 14 mayo 2020];10(6):[aprox. 5 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031407/

  39. Lubrano C, Risi R, Masi D, Gnessi L, Colao A. Is obesity the missing link between COVID-19 severity and air pollution? Environ Pollut [internet]. 2020 [citado 20 mayo 2020];266:[aprox. 6 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397942/pdf/main.pdf

  40. Bouillon R, Marcocci C, Carmeliet G, Bokle D, White JH, Dawson Hughes B, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev [internet]. 2019 [citado 20 mayo 2020];40(4):[aprox. 4 p.]. Disponible en: https://academic.oup.com/edrv/article/40/4/1109/5126915?login=true

  41. Jin Y, Cai L, Cheng Z, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res [internet]. 2020 [citado 20 mayo 2020];7(1):[aprox. 5 p.]. Disponible en: https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-020-0233-6

  42. Hernández N, Martínez S, Ruiz B, Gargallo J, Mallén S, Delgado T. La obesidad: Un elemento de riesgo en pacientes con COVID-19. Rev Sanit Invest [internet]. 2021 [citado 26 ene. 2022];2(5):[aprox. 6 p.]. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8067379

  43. Watanabe M, Risi R, Tuccinardi D, Baquero CJ, Manfrini S, Gnessi L. Obesity and SARS-CoV-2: A population to safeguard. Diabetes Metab Res Rev [internet]. 2020 [citado 20 mayo 2020];36(7):[aprox. 2 p]. Disponible en: https://web.uniroma1.it/dip_dms/sites/default/files/Obesity%20and%20SARS-CoV-2.pdf




2020     |     www.medigraphic.com